BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 3022629)

  • 21. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of ACTH-dependent Cushing's syndrome: comparison of the features in ectopic and pituitary ACTH production.
    Howlett TA; Drury PL; Perry L; Doniach I; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1986 Jun; 24(6):699-713. PubMed ID: 3024870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis.
    Arnaldi G; Tirabassi G; Papa R; Furlani G; Trementino L; Cardinaletti M; Faloia E; Boscaro M
    Eur J Endocrinol; 2009 Jun; 160(6):891-8. PubMed ID: 19321661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Newell-Price J; Morris DG; Drake WM; Korbonits M; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1640-5. PubMed ID: 11932295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The value of corticotropin-releasing hormone (CRH) test for differential diagnosis of Cushing's syndrome].
    Penezić Z; Zarković M; Vujović S; Ivović M; Beleslin B; Ciric J; Drezgić M
    Srp Arh Celok Lek; 2007; 135(1-2):31-7. PubMed ID: 17503565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.
    Blunt SB; Sandler LM; Burrin JM; Joplin GF
    Q J Med; 1990 Nov; 77(283):1113-33. PubMed ID: 2177207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing's syndrome.
    Tyrrell JB; Findling JW; Aron DC; Fitzgerald PA; Forsham PH
    Ann Intern Med; 1986 Feb; 104(2):180-6. PubMed ID: 3004275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing's syndrome.
    Detomas M; Ritzel K; Nasi-Kordhishti I; Wolfsberger S; Quinkler M; Losa M; Tröger V; Kroiss M; Fassnacht M; Vila G; Honegger JB; Reincke M; Deutschbein T
    Front Endocrinol (Lausanne); 2022; 13():955945. PubMed ID: 36277711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The continuous 7-hour intravenous dexamethasone suppression test in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    van den Bogaert DP; de Herder WW; de Jong FH; Biemond P; van der Lely AJ; Lamberts SW
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):193-8. PubMed ID: 10468990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor.
    Malchoff CD; Orth DN; Abboud C; Carney JA; Pairolero PC; Carey RM
    Am J Med; 1988 Apr; 84(4):760-4. PubMed ID: 2840823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic production of ACTH and corticotropin-releasing hormone (CRH).
    Müller OA; von Werder K
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):403-8. PubMed ID: 1327073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone-suppressed corticotropin-releasing hormone stimulation test for diagnosis of mild hypercortisolism.
    Erickson D; Natt N; Nippoldt T; Young WF; Carpenter PC; Petterson T; Christianson T
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2972-6. PubMed ID: 17488798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
    Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome.
    Kaltsas GA; Giannulis MG; Newell-Price JD; Dacie JE; Thakkar C; Afshar F; Monson JP; Grossman AB; Besser GM; Trainer PJ
    J Clin Endocrinol Metab; 1999 Feb; 84(2):487-92. PubMed ID: 10022405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the accuracy of inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome].
    Tóth M; Vajda Z; Görömbey Z; Molnár F; Major L; Toke J; Szabolcs I; Szücs N; Kovács L; Kiss R; Czirják S; Füto L; Gláz E; Góth M; Rácz K
    Orv Hetil; 2007 May; 148(18):843-7. PubMed ID: 17468067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.